Roswell Park Cancer Institute: Esophageal Neoplasms trials

The registry lists 15 Esophageal Neoplasms studies with Roswell Park Cancer Institute as lead sponsor. 0 are open to participants now and 7 have results posted.

Phase 1 5Phase 2 10No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Use of Trifluridine/Tipiracil and Oxaliplatin as Induction Chemotherapy for the Treatment of Resectable Esophageal or Gastroesophageal Junction (GEJ) AdenocarcinomaCompletedNCT04097028Phase 2Results posted
• Botulinum Toxin Type A in Preventing Complications After Surgery in Patients With Esophageal CancerCompletedNCT02965976Phase 2Results posted
• Pralatrexate and Oxaliplatin in Treating Patients With Unresectable or Metastatic Esophageal, Stomach, or Gastroesophageal Junction CancerCompletedNCT01178944Phase 2Results posted
• Acceptability of Less Harmful Alternatives to CigarettesCompletedNCT00957424Not applicableResults posted
• Bupropion in Helping Adults Stop SmokingCompletedNCT00534001Phase 2Results posted
• Erlotinib and Radiation Therapy in Treating Older Patients With Stage I, Stage II, Stage III, or Stage IV Esophageal CancerCompletedNCT00524121Phase 2Results posted
• Oxaliplatin, Capecitabine, and Radiation Therapy in Patients Undergoing Surgery for Stage II, III, IV Esophageal CancerCompletedNCT00470184Phase 2Results posted
• Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid TumorsCompletedNCT01522820Phase 1
• Study for Determination of Feasibility and Toxicity of Pre-Treatment With HPPH (2-1[1-Hexyloxyethyl]-2 Devinyl Pyropheophorbide-a) Photodynamic Therapy Prior to Chemoradiation in Non-Operable Patients With Obstructive Esophageal CancerWithdrawnNCT01035437Not applicable
• Vorinostat, Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Upper Gastrointestinal CancerCompletedNCT00537121Phase 1
• Sunitinib, Irinotecan, Fluorouracil, and Leucovorin In Treating Patients With Advanced Stomach Cancer or Gastroesophageal CancerTerminatedNCT00524186Phase 1
• Photodynamic Therapy in Treating Patients With Precancerous Esophageal Conditions or Early Stage Esophageal CancerCompletedNCT00281736Phase 2
• Oxaliplatin, Gefitinib, and Radiation Therapy in Treating Patients With Locally Advanced or Metastatic Esophageal CancerTerminatedNCT00093652Phase 1/2
• Photodynamic Therapy Using HPPH in Treating Patients With Obstructive Esophageal TumorsCompletedNCT00060268Phase 1/2
• Photodynamic Therapy in Treating Patients With Early Esophageal CancerCompletedNCT00002935Phase 2